Emerging Pharmacologic Therapies for Irritable Bowel Syndrome (Q37778790)

23 August 2017

1 reference

title

Emerging pharmacologic therapies for irritable bowel syndrome (English)

1 reference

23 August 2017

Emerging Pharmacologic Therapies for Irritable Bowel Syndrome (English)

1 reference

https://api.crossref.org/works/10.1007/S11894-010-0124-1

19 June 2024

1 reference

4

Michael Camilleri

1 reference

23 August 2017

1

Noriaki Manabe

1 reference

23 August 2017

Archana S. Rao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20694841

19 June 2024

Banny S. Wong

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20694841

19 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20694841

19 June 2024

publication date

1 October 2010

1 reference

full work available at URL

23 August 2017

http://www.current-reports.com/1522-8037/12/408

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20694841

http://link.springer.com/content/pdf/10.1007/s11894-010-0124-1.pdf

19 June 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S11894-010-0124-1

http://link.springer.com/article/10.1007/s11894-010-0124-1/fulltext.html

19 June 2024

1 reference

https://api.crossref.org/works/10.1007/S11894-010-0124-1

http://link.springer.com/content/pdf/10.1007/s11894-010-0124-1

19 June 2024

1 reference

https://api.crossref.org/works/10.1007/S11894-010-0124-1

Current gastroenterology reports

19 June 2024

published in

1 reference

23 August 2017

volume

12

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

408-416

1 reference

Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0124-1

Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects

21 January 2018

1 reference

12 December 2020

Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome

1 reference

12 December 2020

Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome

1 reference

12 December 2020

Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry

1 reference

12 December 2020

Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome

1 reference

12 December 2020

Prucalopride, a systemic enterokinetic, for the treatment of constipation

1 reference

12 December 2020

Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function

1 reference

12 December 2020

Pilot study on the effect of linaclotide in patients with chronic constipation

1 reference

12 December 2020

Evaluation of crofelemer in the treatment of diarrhea-predominant irritable bowel syndrome patients

1 reference

12 December 2020

Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers.

1 reference

12 December 2020

Pharmacological profile of ramosetron, a novel therapeutic agent for IBS

1 reference

12 December 2020

Current and novel therapeutic options for irritable bowel syndrome management

1 reference

12 December 2020

Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study

1 reference

12 December 2020

Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles

1 reference

12 December 2020

Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimulated by a novel agonist of the ClC-2 chloride channel, lubiprostone

1 reference

12 December 2020

Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation

1 reference

12 December 2020

Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome

1 reference

12 December 2020

Irritable bowel syndrome: a technical review for practice guideline development

1 reference

12 December 2020

A phase II trial of the novel serotonin type 3 receptor antagonist ramosetron in Japanese male and female patients with diarrhea-predominant irritable bowel syndrome

1 reference

12 December 2020

Efficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndrome

1 reference

12 December 2020

The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome

1 reference

12 December 2020

Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation.

1 reference

12 December 2020

Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder

1 reference

12 December 2020

Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans

1 reference

12 December 2020

Effects of serotonin 5-HT3 receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome

1 reference

12 December 2020

Treating irritable bowel syndrome: overview, perspective and future therapies

1 reference

12 December 2020

Efficacy of linaclotide for patients with chronic constipation

1 reference

12 December 2020

Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial

1 reference

12 December 2020

Review article: new receptor targets for medical therapy in irritable bowel syndrome

1 reference

12 December 2020

The serotonin signaling system: from basic understanding to drug development for functional GI disorders

1 reference

12 December 2020

Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome

1 reference

12 December 2020

Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives

1 reference

12 December 2020

Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Systematic Evaluation of the Causes of Chronic Watery Diarrhea With Functional Characteristics

1 reference

12 December 2020

A placebo-controlled trial of prucalopride for severe chronic constipation

1 reference

12 December 2020

Colonoscopy: virtual, optical, or chromoscopic?

series ordinal

13

1 reference

https://api.crossref.org/works/10.1007/S11894-010-0124-1

19 June 2024

Identifiers

1 reference

23 August 2017

1 reference